Primer on Tumor Immunology and Cancer Immunotherapyâ„¢
|
The SITC 2014 Primer Presentation Archive is supported through a generous contribution from Prometheus Laboratories Inc. Access slide decks and video via the links in the schedule below.
|
 |
Thursday, November 6, 2014
| 7:00 am – 8:00 am | Breakfast |
| 8:00 am – 8:10 am | Welcome and Overview  .25 AMA PRA Category 1 Credits™ Willem W. Overwijk, PhD – University of Texas, MD Anderson Cancer Center |
| 8:10 am – 10:10 am | Session I: Basic Immunology – A Brief Overview 2 AMA PRA Category 1 Credits™ |
| 8:10 am – 8:45 am | Introduction to Innate Immunity  Vincenzo Bronte, MD – University of Verona |
| 8:45 am – 9:20 am | Dendritic Cells: Basic Biology and Therapeutic Use Lisa H. Butterfield, PhD – University of Pittsburgh |
| 9:20 am – 9:55 am | Overview of Adaptive Immunity Jonathan Powell, MD, PhD – Johns Hopkins Hospital |
| 9:55 am – 10:10 am | Panel Questions and Answers |
| 10:10 am – 10:25 am | Break |
| 10:25 am – 12:30 pm | Session II: Treating Tumors with Passive Immunotherapy 2 AMA PRA Category 1 Credits™ |
| 10:25 am – 10:30 am | Session II Introduction Willem W. Overwijk, PhD – University of Texas, MD Anderson Cancer Center |
| 10:30 am – 11:05 am | Adoptive T Cell Therapy Carl H. June, MD – University of Pittsburgh |
| 11:05 am – 11:40 am | Anti-Tumor Antibodies Sattva S. Neelapu, MD – University of Texas, MD Anderson Cancer Center |
| 11:40 am – 12:15 pm | Obstacles to Driving an Immune Response Margaret K. Callahan, MD, PhD – Memorial Sloan-Kettering Cancer Center |
| 12:15 pm – 12:30 pm | Panel Questions and Answers |
| 12:30 pm – 1:30 pm | Lunch |
| 1:30 pm – 3:00 pm | Session III: Active Immunotherapy: Unleashing the Patient’s Own Immune System 1.5 AMA PRA Category 1 Credits™ |
| 1:30 pm – 1:35 pm | Session III Introduction Padmanee Sharma, MD, PhD – University of Texas, MD Anderson Cancer Center |
| 1:35 pm – 2:10 pm | Cancer Vaccines Willem W. Overwijk, PhD – University of Texas, MD Anderson Cancer Center |
| 2:10 pm – 2:45 pm | Targeting Immune Checkpoints in Cancer Therapy: New Insights and Opportunities James P. Allison, PhD – University of Texas, MD Anderson Cancer Center |
| 2:45 pm – 3:00 pm | Panel Questions and Answers |
| 3:00 pm – 3:15 pm | Break |
| 3:15 pm – 4:45 pm | Session IV: Immune Monitoring: Figuring Out How it All Works 1.5 AMA PRA Category 1 Credits™ |
| 3:15 pm – 3:20 pm | Session IV Introduction Padmanee Sharma, MD, PhD – University of Texas, MD Anderson Cancer Center |
| 3:20 pm – 3:55 pm | Human ImmunoMonitoring: A Systems Biology Approach Sacha Gnjatic, PhD – Icahn School of Medicine, Mount Sinai |
| 3:55 pm – 4:30 pm | Pre-Surgical Clinical Trial Design for Immune Monitoring Padmanee Sharma, MD, PhD – University of Texas, MD Anderson Cancer Center |
| 4:30 pm – 4:45 pm | Panel Questions and Answers |
| 4:45 pm – 5:00 pm | Closing Remarks .25 AMA PRA Category 1 Credits™ Padmanee Sharma, MD, PhD – University of Texas, MD Anderson Cancer Center |
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
